IBOK
JAZZ icon

Independence Bank of Kentucky’s Jazz Pharmaceuticals JAZZ Stock Holding History

Independence Bank of Kentucky’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25
Closed -$3.29K – 740
2025
Q3 		$3.29K Hold
25
– – ﹤0.01% 595
2025
Q2 		$2.65K Buy
+25
New +$2.72K ﹤0.01% 590
2024
Q4 		– Sell
-12
Closed -$1.34K – 632
2024
Q3 		$1.34K Buy
+12
New +$1.31K ﹤0.01% 577

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Independence Bank of Kentucky's JAZZ Position: Q4 2025 in Review

Independence Bank of Kentucky sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2025, closing a stake of 25 shares — an estimated $3.29K sold.

Independence Bank of Kentucky first reported a position in JAZZ in Q3 2024 and held it in 3 quarters. The position peaked at $3.29K in Q3 2025. 574 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.

  • Independence Bank of Kentucky reported no remaining Jazz Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Independence Bank of Kentucky sold 25 Jazz Pharmaceuticals shares in Q4 2025, an estimated $3.29K.
  • Independence Bank of Kentucky first reported a position in Jazz Pharmaceuticals in Q3 2024 and held it in 3 quarters.
  • Independence Bank of Kentucky's Jazz Pharmaceuticals position peaked at $3.29K in Q3 2025.
  • 574 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.

Based on Independence Bank of Kentucky's 13F filing for Q4 2025, filed 20 Jan 2026.